Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03522246
Title A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy (ATHENA)
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Clovis Oncology, Inc.
Indications

peritoneum cancer

fallopian tube cancer

ovary epithelial cancer

Therapies

Rucaparib

Nivolumab

Nivolumab + Rucaparib

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.